Fasting hyperglucagonemia and delayed glucagon-suppression are strongly linked to obesity and metabolic syndrome. Rising glucagon during OGTT may be a rare phenomenon. It occurs in insulin-sensitive individuals with a tendency toward hypoglycemia, but does not necessarily indicate metabolic health. This evidence concerns the gene INS and obesity disorder.